ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 51 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2018. The put-call ratio across all filers is 1.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $17 | -99.7% | 99,893 | +284.6% | 0.00% | – |
| Q3 2022 | $5,000 | -96.3% | 25,970 | -88.4% | 0.00% | -100.0% |
| Q4 2021 | $136,000 | -31.7% | 224,561 | +9.6% | 0.01% | -22.2% |
| Q3 2021 | $199,000 | -39.0% | 204,870 | -40.8% | 0.02% | -21.7% |
| Q1 2021 | $326,000 | +951.6% | 346,296 | +772.7% | 0.02% | +360.0% |
| Q3 2020 | $31,000 | -27.9% | 39,683 | +92.7% | 0.01% | +150.0% |
| Q1 2019 | $43,000 | -44.2% | 20,588 | -14.1% | 0.00% | -33.3% |
| Q2 2018 | $77,000 | -82.6% | 23,963 | -76.1% | 0.00% | -87.0% |
| Q4 2017 | $442,000 | – | 100,363 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROW Partners, LLC | 325,000 | $2,077,000 | 1.27% |
| DAFNA Capital Management LLC | 125,000 | $799,000 | 0.82% |
| BARD ASSOCIATES INC | 170,925 | $1,094,000 | 0.46% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 525,000 | $3,355,000 | 0.36% |
| SOPHROSYNE CAPITAL LLC | 42,000 | $267,000 | 0.23% |
| Granite Point Capital Management, L.P. | 205,000 | $1,310,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 407,024 | $2,601,000 | 0.17% |
| SCOGGIN MANAGEMENT LP | 150,000 | $959,000 | 0.08% |
| Geduld E E | 25,000 | $160,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 45,000 | $288,000 | 0.05% |